Skip to main content

Treace Medical Concepts, Inc.

TMCI
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001630627

In the last 90 days, Treace Medical Concepts, Inc. insiders filed 1 open-market purchase and 0 sales; 116 institutions reported holding it in 13F filings for Q2 2026, worth $126.8M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Treace Medical Concepts, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of TMCI: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders7775−2
Shares29.2M20.4M−8.84M (−30.3%)
Value$431.0M$385.4M−$45.6M (−10.6%)

New holders (11)

Institutions that held Treace Medical Concepts, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to TMCI in Q1 2022
InstitutionSharesValue% of portfolio
Dakota Wealth Management85,574$1.62M0.13%
Balyasny Asset Management LLC20,109$380.0K0.00%
Twinbeech Capital LP17,831$337.0K0.01%
Goldman Sachs Group Inc13,739$260.0K0.00%
Credit Suisse AG10,536$199.0K0.00%
Gabelli & Co Investment Advisers, Inc.10,000$189.0K0.02%
Barclays PLC8,350$157.0K0.00%
Amalgamated Bank4,898$93.0K0.00%
Amalgamated Financial Corp.4,898$93.0K0.00%
Ensign Peak Advisors, Inc900$17.0K0.00%
TCWP LLC215$4.00K0.00%

Sold out (13)

Institutions that held Treace Medical Concepts, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of TMCI in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Federated Hermes, Inc.450,000$8.39M
Norges Bank198,119$3.69M
Endurant Capital Management LP57,175$1.07M
Alpha Paradigm Partners, LLC37,130$692.0K
Marshall Wace, LLP33,908$633.0K
PDT Partners, LLC19,974$372.0K
Gyon Technologies Capital Management, LP11,000$205.0K
C WorldWide Group Holding A/S5,000$93.0K
Agf Investments Inc.492$9.00K
Advisor Group Holdings, Inc.200$4.00K
CWM, LLC179$3.00K
Point72 Hong Kong Ltd101$2.00K
Covestor Ltd18$0